Paige is a technology company helping pathologists, oncologists and clinicians make faster, more informed diagnostic and treatment decisions in cancer, through the use of advanced Artificial Intelligence (AI). We are uniquely positioned to do this by mining decades of data from world renowned cancer centers and are transforming the way cancer is diagnosed and treated.
Paige is the first company to develop clinical grade AI tools for the pathologist, which resulted in our receiving the first FDA approval for an AI product in pathology. Paige has also received FDA-clearance for our digital viewer, FullFocus®, and CE-IVD and UKCA clearance for our diagnostic AI in prostate and breast cancer.
We have also established multiple relationships with biopharma, laboratory and equipment manufacturers that enable Paige to develop a full solution for busy laboratories, ready to help patients receive better diagnoses and treatment.